Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis

Abstract Background Anaplastic lymphoma kinase (ALK) overexpression and gene alterations have been detected in several mesenchymal tumors, with significant implications for diagnosis, therapy and prognosis. However, few studies have investigated the correlation between ALK expression status and clin...

Full description

Bibliographic Details
Main Authors: Ying Wu, Beibei Gao, Qin Xia, Yili Zhu, Na Wang, Xiaona Chang, Bo Huang, Danju Luo, Jiwei Zhang, Peng Zhang, Heshui Shi, Jun Fan, Xiu Nie
Format: Article
Language:English
Published: BMC 2023-04-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-023-03019-4
_version_ 1827956786071601152
author Ying Wu
Beibei Gao
Qin Xia
Yili Zhu
Na Wang
Xiaona Chang
Bo Huang
Danju Luo
Jiwei Zhang
Peng Zhang
Heshui Shi
Jun Fan
Xiu Nie
author_facet Ying Wu
Beibei Gao
Qin Xia
Yili Zhu
Na Wang
Xiaona Chang
Bo Huang
Danju Luo
Jiwei Zhang
Peng Zhang
Heshui Shi
Jun Fan
Xiu Nie
author_sort Ying Wu
collection DOAJ
description Abstract Background Anaplastic lymphoma kinase (ALK) overexpression and gene alterations have been detected in several mesenchymal tumors, with significant implications for diagnosis, therapy and prognosis. However, few studies have investigated the correlation between ALK expression status and clinicopathological characteristics in patients with gastrointestinal stromal tumors (GISTs). Methods A total of 506 GIST patients were enrolled. Sanger sequencing was employed to detect c-KIT and PDGFRA gene mutations. The tissue microarray (TMA) technique and immunohistochemistry were employed to identify the ALK (clone: 1A4 and D5F3) expression status in the tumor tissues. The ALK gene variants of IHC-positive cases were analyzed by fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS). The clinicopathological data were analyzed using SPSS Statistics 26.0. Results Among the 506 GIST patients, the c-KIT mutation accounted for 84.2% (426/506), followed by PDGFRA mutation (10.3%, 52/506), while the wild-type accounted for the least (5.5%, 28/506). ALK-positive expression was detected in PDGFRA-mutant GISTs (7.7%, 4/52) but negative for c-KIT-mutant or wild-type GISTs by IHC. Four ALK IHC-positive patients were all male. The tumors all occurred outside the stomach. The predominant patterns of growth were epithelioid (2/4), spindle (1/4), and mixed type (1/4). They were all identified as high-risk classification according to the National Institutes of Health (NIH) classification. Aberrant ALK mutations were not identified by DNA-based NGS except in one of the 4 cases with amplification by FISH. Conclusion Our study revealed 7.7% (4/52) of ALK expression in PDGFRA-mutant GISTs, indicating that molecular tests were required to rule out the possibility of PDGFRA-mutant GISTs when encountering ALK-positive mesenchymal tumors with CD117-negative or weakly positive in immunohistochemical staining.
first_indexed 2024-04-09T15:09:26Z
format Article
id doaj.art-e2f6b10db1064193bc3830be0a06a4d8
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-04-09T15:09:26Z
publishDate 2023-04-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-e2f6b10db1064193bc3830be0a06a4d82023-04-30T11:18:10ZengBMCWorld Journal of Surgical Oncology1477-78192023-04-012111910.1186/s12957-023-03019-4Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosisYing Wu0Beibei Gao1Qin Xia2Yili Zhu3Na Wang4Xiaona Chang5Bo Huang6Danju Luo7Jiwei Zhang8Peng Zhang9Heshui Shi10Jun Fan11Xiu Nie12Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Anaplastic lymphoma kinase (ALK) overexpression and gene alterations have been detected in several mesenchymal tumors, with significant implications for diagnosis, therapy and prognosis. However, few studies have investigated the correlation between ALK expression status and clinicopathological characteristics in patients with gastrointestinal stromal tumors (GISTs). Methods A total of 506 GIST patients were enrolled. Sanger sequencing was employed to detect c-KIT and PDGFRA gene mutations. The tissue microarray (TMA) technique and immunohistochemistry were employed to identify the ALK (clone: 1A4 and D5F3) expression status in the tumor tissues. The ALK gene variants of IHC-positive cases were analyzed by fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS). The clinicopathological data were analyzed using SPSS Statistics 26.0. Results Among the 506 GIST patients, the c-KIT mutation accounted for 84.2% (426/506), followed by PDGFRA mutation (10.3%, 52/506), while the wild-type accounted for the least (5.5%, 28/506). ALK-positive expression was detected in PDGFRA-mutant GISTs (7.7%, 4/52) but negative for c-KIT-mutant or wild-type GISTs by IHC. Four ALK IHC-positive patients were all male. The tumors all occurred outside the stomach. The predominant patterns of growth were epithelioid (2/4), spindle (1/4), and mixed type (1/4). They were all identified as high-risk classification according to the National Institutes of Health (NIH) classification. Aberrant ALK mutations were not identified by DNA-based NGS except in one of the 4 cases with amplification by FISH. Conclusion Our study revealed 7.7% (4/52) of ALK expression in PDGFRA-mutant GISTs, indicating that molecular tests were required to rule out the possibility of PDGFRA-mutant GISTs when encountering ALK-positive mesenchymal tumors with CD117-negative or weakly positive in immunohistochemical staining.https://doi.org/10.1186/s12957-023-03019-4Gastrointestinal stromal tumorALK expressionClinicopathological features
spellingShingle Ying Wu
Beibei Gao
Qin Xia
Yili Zhu
Na Wang
Xiaona Chang
Bo Huang
Danju Luo
Jiwei Zhang
Peng Zhang
Heshui Shi
Jun Fan
Xiu Nie
Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
World Journal of Surgical Oncology
Gastrointestinal stromal tumor
ALK expression
Clinicopathological features
title Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
title_full Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
title_fullStr Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
title_full_unstemmed Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
title_short Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
title_sort anaplastic lymphoma kinase expression in pdgfra mutated gastrointestinal stromal tumors probably correlates with poor prognosis
topic Gastrointestinal stromal tumor
ALK expression
Clinicopathological features
url https://doi.org/10.1186/s12957-023-03019-4
work_keys_str_mv AT yingwu anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT beibeigao anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT qinxia anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT yilizhu anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT nawang anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT xiaonachang anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT bohuang anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT danjuluo anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT jiweizhang anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT pengzhang anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT heshuishi anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT junfan anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis
AT xiunie anaplasticlymphomakinaseexpressioninpdgframutatedgastrointestinalstromaltumorsprobablycorrelateswithpoorprognosis